⚡ electrical engineering

Creatinine biosensor development and characterization by a combined experimental and kinetic modelling approach using a field-effect capacitor modified with creatinine deiminase

This paper presents the development and characterization of a portable creatinine biosensor based on a Ta2O5/SiO2/p-Si/Al EISCAP field-effect capacitor modified with creatinine deiminase, utilizing a combined experimental and kinetic modeling approach to evaluate its performance across varying buffer concentrations and determine key enzymatic parameters.

Original authors: Astghik Tsokolakyan

Published 2026-07-14

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Astghik Tsokolakyan

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine your kidneys are the body's ultimate bouncers, constantly checking the ID of your blood to make sure everything is running smoothly. One of the most important things they check is a tiny waste product called creatinine. If the bouncer sees too much creatinine, it's a red flag that the kidneys might be in trouble. Usually, to check this, you have to send a sample to a giant, fancy lab with expensive machines and scientists in white coats. But what if you could have a tiny, portable detective that does the job right at your bedside?

That's exactly what researcher Astghik Tsokolakyan is trying to build. She hasn't built a magic wand yet, but she has created a very clever, tiny sensor that acts like a "creatinine sniffer."

The Detective's Toolkit: A Tiny Capacitor

The heart of this invention is a special chip called an EISCAP. Think of it as a super-sensitive electronic ear that listens to changes in acidity (pH). The chip is made of layers: a silicon base, some insulating glass, and a top layer of Tantalum Oxide ( $Ta_2O_5$ ) that loves to react to pH changes.

To make this chip smell creatinine, Tsokolakyan gave it a two-step makeover:

The Sticky Layer: First, she coated the chip with a polymer called PAH. Imagine this as a layer of microscopic Velcro or a sticky net.
The Enzyme Team: Next, she sprinkled on creatinine deiminase (CD). This is a biological enzyme, which you can think of as a tiny, hungry Pac-Man.

How the "Sniffer" Works

Here is the magic trick: When creatinine (the waste product) meets the hungry Pac-Man enzyme, the enzyme eats it and breaks it down. But there's a catch—when the enzyme digests creatinine, it releases ammonia.

Ammonia is like a chemical firework that makes the immediate area around the chip less acidic (more basic). The EISCAP chip is so sensitive that it can feel this tiny shift in acidity. It translates the chemical change into an electrical signal, telling us, "Hey, I just smelled some creatinine!"

The Buffer Problem: The "Sponge" Effect

The researchers ran into a tricky puzzle. They tested their sensor in three different "baths" of liquid, each with a different amount of buffer (a chemical sponge that soaks up pH changes).

The Weak Sponge (0.33 mM): In this bath, the sponge is weak. When the enzyme releases ammonia, the pH changes wildly. The sensor goes crazy with a big signal! It can detect very small amounts of creatinine (starting at 0.01 mM), but it gets "full" and stops working if there is too much creatinine (around 1 mM).
The Strong Sponge (33 mM): In this bath, the sponge is huge. It soaks up the ammonia immediately, so the pH barely changes. The sensor is calm and only reacts to huge amounts of creatinine (starting at 1 mM), but it can handle a lot more before getting full (up to 10 mM).
The Sweet Spot (3.3 mM): This was the Goldilocks zone. It offered the best balance, detecting creatinine from 0.3 mM to 5 mM with a very strong signal.

The paper explicitly shows that buffer capacity is the boss. If you want to detect low levels of creatinine, you need a weak buffer. If you want to measure high levels (like in urine), you need a strong buffer to stop the sensor from getting overwhelmed.

The Math Detective: Guessing the Rules

The team didn't just watch the sensor; they built a computer model to understand why it behaved that way. They used a set of math rules (kinetic modeling) to figure out how fast the enzyme eats and how well it grabs the creatinine.

They found that the enzyme's "hunger" (called the Michaelis-Menten constant, or $K_M$ ) was incredibly low in the weak and medium buffers, meaning it grabbed creatinine very tightly (around 0.01 mM). But in the strong buffer, it seemed a bit less eager (0.04 mM).

They also calculated how fast the enzyme could work at full speed ( $V_{max}$ ). In the strong buffer, the system seemed to work much faster (6.83 M s⁻¹) compared to the weak buffer (0.19 M s⁻¹). However, the authors are careful to say these aren't the "true" speed limits of the enzyme in a test tube. Instead, these are apparent speeds—how fast the whole system (enzyme + sticky layer + buffer) works together. It's like measuring how fast a car drives on a specific road with traffic, rather than the car's top speed on an empty track.

What This Means (and What It Doesn't)

The paper proves that this CD/PAH-EISCAP sensor works. It can detect creatinine, and its performance changes predictably based on how "spongy" the liquid is. The sensor is stable, can recover its signal quickly, and gives a clear electrical reading.

However, the paper does not claim this is a finished medical device ready for your doctor's office.

It has not been tested on real human blood or urine yet.
It has not proven it can ignore other chemicals that might trick it (selectivity).
It has not shown how long it lasts over months of use.

The authors suggest that this combined approach—mixing real experiments with computer modeling—is a great way to design better sensors in the future. They have built a solid prototype that works in a controlled lab bath, but the journey to a real-world, pocket-sized kidney checker is still ahead.

In short: They built a tiny, pH-sensitive electronic nose that can smell creatinine by watching how a hungry enzyme changes the acidity of its surroundings. They found that the "sponge-ness" of the liquid controls how much creatinine the nose can smell, and they used math to figure out exactly how the enzyme behaves inside the sensor. It's a promising step, but the real test in the messy world of human biology is yet to come.

Technical Summary: Creatinine Biosensor Development via Combined Experimental and Kinetic Modelling

Problem Statement
Monitoring creatinine levels is a standard clinical practice for assessing renal function in conditions such as acute kidney injury (AKI) and chronic kidney disease (CKD). While laboratory-based assays (e.g., Jaffe reaction, enzymatic methods) remain the gold standard, they require centralized infrastructure and trained personnel. This limitation drives the need for portable, point-of-care (POC) biosensors. However, the performance of pH-based enzymatic biosensors is highly sensitive to measurement conditions, particularly buffer capacity, ionic strength, and the enzyme immobilization matrix. These factors modulate local pH gradients and signal amplitude, making it difficult to distinguish intrinsic sensor behavior from buffer-induced effects. Consequently, a robust characterization approach is required to simultaneously evaluate biosensor performance and the behavior of the immobilized enzyme layer under varying conditions.

Methodology
The study reports the development and characterization of a creatinine-sensitive biosensor based on an electrolyte-insulator-semiconductor capacitive (EISCAP) field-effect sensor.

Device Architecture: The sensor utilizes a Ta₂O₅/SiO₂/p-Si/Al structure. The pH-sensitive Ta₂O₅ gate was modified via sequential adsorption of poly(allylamine hydrochloride) (PAH) and creatinine deiminase (CD). PAH serves as a polyelectrolyte matrix to facilitate electrostatic enzyme immobilization.
Working Principle: The detection mechanism relies on the CD-catalyzed hydrolysis of creatinine into N-methylhydantoin and ammonia. The subsequent acid-base equilibrium of ammonia (NH₃/NH₄⁺) generates a local pH increase near the sensor surface, which is transduced by the pH-sensitive Ta₂O₅ layer as a shift in the capacitance-voltage (C-V) characteristics.
Experimental Design: The CD/PAH-EISCAP platform was tested in phosphate-buffered saline (PBS) with three distinct buffer concentrations (0.33 mM, 3.3 mM, and 33 mM) to evaluate the effect of buffer capacity on sensitivity and linear range. Creatinine concentrations ranged from 0.01 to 50 mM depending on the buffer strength.
Kinetic Modeling: A theoretical kinetic modeling framework, previously adapted for urea detection, was applied to the experimental calibration data. The model incorporates Michaelis-Menten enzyme kinetics, acid-base equilibria (involving the phosphate buffer, ammonia, and N-methylhydantoin), and transport processes. It assumes steady-state conditions and treats the enzyme layer as a thin film where substrate diffusion is fast relative to reaction kinetics. The model was used to extract apparent kinetic parameters, specifically the Michaelis-Menten constant ( $K_M$ ) and the maximum reaction rate ( $V_{max}$ ).

Key Contributions

Fabrication of a CD/PAH-EISCAP Platform: The study successfully demonstrates the fabrication of a creatinine biosensor using a Ta₂O₅-gated EISCAP structure modified with a PAH/CD enzymatic layer.
Systematic Buffer Capacity Analysis: The research systematically investigates how buffer concentration (0.33, 3.3, and 33 mM) influences the sensor's dynamic linear range and sensitivity, demonstrating a clear trade-off between signal amplitude and the upper limit of the linear detection range.
Integration of Kinetic Modeling: A significant contribution is the application of a kinetic modeling framework to extract apparent kinetic parameters ( $K_M$ and $V_{max}$ ) from potentiometric data. This approach allows for the characterization of the immobilized enzyme layer's operational behavior rather than just the bulk enzyme properties.
Surface Characterization: The study includes Atomic Force Microscopy (AFM) analysis confirming the formation of the enzyme-containing layer, showing increased surface roughness after CD immobilization compared to the PAH-only layer.

Results

Sensor Performance: The biosensor exhibited distinct voltage shifts corresponding to creatinine concentration. The sensitivity and linear range were strongly dependent on buffer capacity:
- 0.33 mM PBS: Sensitivity of 64 mV dec⁻¹; linear range 0.05–1 mM.
- 3.3 mM PBS: Sensitivity of 75 mV dec⁻¹; linear range 0.3–5 mM.
- 33 mM PBS: Sensitivity of 38 mV dec⁻¹; linear range 1–10 mM.
- Higher buffer capacity suppressed local pH changes, reducing signal amplitude but extending the linear detection range to higher creatinine concentrations.
Kinetic Parameters: The kinetic model successfully fitted the experimental data (with low $\chi^2$ $χ^{2}$ values). The extracted apparent parameters were:
- $K_M$ : 0.01 mM (0.33 and 3.3 mM PBS) and 0.04 mM (33 mM PBS).
- $V_{max}$ : Increased with buffer capacity (0.19 M s⁻¹, 2.34 M s⁻¹, and 6.83 M s⁻¹, respectively).
Interpretation of Parameters: The authors note that the fitted $K_M$ and $V_{max}$ values represent the apparent operational constants of the surface-confined CD/PAH system, influenced by transport, buffer capacity, and interfacial pH transduction, rather than the intrinsic kinetic constants of free CD in bulk solution.
Stability: The sensor demonstrated complete signal recovery and no observable delay when alternately exposed to creatinine and creatinine-free buffer, indicating good short-term operational stability.

Significance and Claims
The paper claims that the combined experimental-modeling workflow provides a robust method for characterizing enzymatic potentiometric biosensors. By extracting apparent kinetic parameters, the approach offers insights into the behavior of the immobilized enzyme layer that are not accessible through simple calibration curves alone.

The authors state that the CD/PAH-EISCAP platform shows potential for creatinine analysis in biologically relevant concentration ranges, with the 3.3 mM PBS condition identified as offering the best balance between sensitivity and linear range. However, the paper maintains a modest scope regarding clinical application, explicitly stating that the current study validates the sensor in PBS buffers. The authors conclude that future work is necessary to validate selectivity, assess matrix effects, and test the platform in complex biological media (such as undiluted serum or urine) before it can be considered suitable for decentralized monitoring. The study does not claim immediate clinical deployment but rather establishes a foundational characterization framework for optimizing such sensors.